Women’s Health Update: Pill Myths, Menopause Program, US Contraceptives, Asherman Device & More
From online misinformation affecting contraceptive use, US-funded contraceptives stuck in Belgium, and Astellas’ global menopause program to PM Modi’s women’s health campaign—this week’s signals are robust. We span women’s health, policy, clinical innovation, digital health, and more, with funding and regulatory advances across areas, underscoring the impact of social media on health decisions and the growing focus on inclusive care.
In Today’s Newsletter
💊 Online Misinformation Putting Women Off Contraceptive Pill
Context: Myths on social media platforms like TikTok drive a nocebo effect for women on contraceptives.
Key Point: Study reveals psychological side-effects linked to negative expectations about the pill.
Implication: Affects women’s decision to continue using the pill, contributing to declining usage rates.
💉 Belgian Ministry Confirms US-Funded Contraceptives Still in Storage
Context: US-funded contraceptives worth $10M remain in storage due to legal issues surrounding destruction.
Key Point: Belgium’s local laws prevent incineration of usable medicines, despite plans for destruction.
Implication: International reproductive rights groups criticize the waste, while supplies remain unused.
🌸 Astellas Launches Global Menopause Inclusivity Program
Context: Astellas Pharma unveils a global program to support women experiencing menopause in the workplace.
Key Point: The program aims to reduce stigma and improve support with resources for employers and employees.
Implication: Could transform workplace cultures and improve the well-being of women navigating menopause.
🩺 PM Modi to Launch ‘Swasth Nari, Sashakt Parivar Abhiyaan’ on 75th Birthday
Context: Prime Minister Narendra Modi to launch India’s largest-ever women’s health initiative.
Key Point: The campaign will establish over 100,000 health camps focusing on women’s and child health.
Implication: Aims to improve access to health services and raise awareness of non-communicable diseases in India.
🧬 Cook MyoSite and Veristat Partner on Women’s Health Study
Context: Phase III study for cell therapy targeting chronic fecal incontinence due to obstetric anal sphincter injury.
Key Point: Successful enrollment of 100+ participants marks a key milestone in a crucial clinical trial.
Implication: Could offer new hope for women suffering from a condition with few treatment options.
🧠 Eli Lilly Teams Up with Julianne Moore for Brain Health Campaign
Context: Julianne Moore joins Eli Lilly’s campaign to raise awareness of brain health, especially for Alzheimer’s.
Key Point: Focuses on cognitive assessments, dementia risk, and the importance of brain health at all ages.
Implication: The campaign may drive greater awareness of Alzheimer’s and encourage proactive care.
🩺 US FDA Approves First Medical Device for Asherman Syndrome
Context: The FDA has approved the Womed Leaf® for treating intrauterine adhesions, a major cause of infertility.
Key Point: This is the first device approved to prevent recurrence of adhesions after surgical treatment.
Implication: The device could improve fertility outcomes and reduce recurrence in women with Asherman syndrome.
🧑🔬 Conceivable Life Sciences Raises $50M for AI and Robotics in IVF
Context: Conceivable Life Sciences secures $50M to enhance AI-driven IVF processes.
Key Point: The funding will support the development of AI-powered automation in the IVF lifecycle.
Implication: Could significantly reduce IVF costs, increase consistency in outcomes, and improve patient experience.
Why It Matters
- Women’s Health Innovations: The growing focus on improving women’s health through innovative technologies, education, and support systems reflects a pivotal shift in healthcare. From fertility treatments to menopause inclusivity programs, the health and well-being of women are receiving increasing attention globally.
- Social Media Impact: The role of misinformation on social media platforms is becoming more evident in public health, particularly in the case of contraceptive use. Addressing these myths is crucial in ensuring women have accurate information to make informed health choices.
- Regulatory and Policy Changes: In both the US and Europe, government policies and actions (such as the disposal of contraceptive supplies or the approval of medical devices) play a critical role in shaping women’s healthcare options and accessibility.
📢 Stay Ahead in Women’s Health Research!
✅ Contact LucidQuest at info@lqventures.com for strategic guidance on women’s health innovations and clinical research.
FAQ
What impact is online misinformation having on contraceptive use?
Social media myths about contraceptive pills, particularly on platforms like TikTok, are causing women to experience psychological side effects, leading to lower usage rates and influencing health decisions.
Why is the US contraceptive stockpile still in Belgium?
Legal issues in Belgium prevent the incineration of usable medicines, resulting in a $10M worth of contraceptives remaining unused, despite plans for their destruction.
What is Astellas Pharma’s initiative for menopause?
Astellas Pharma has launched a global program to reduce menopause-related stigma in workplaces and provide support for women experiencing menopause.
How is Cook MyoSite advancing women’s health with its new clinical trial?
Cook MyoSite’s partnership with Veristat is aiming to provide a new cell therapy for chronic fecal incontinence, a condition affecting many women after childbirth, with limited treatment options.
What is the significance of the Womed Leaf® device?
The FDA’s approval of Womed Leaf® is a breakthrough for women with Asherman syndrome, offering a new device to prevent intrauterine adhesions and improve fertility outcomes.
References
- https://www.theguardian.com/society/2025/sep/13/online-misinformation-putting-women-off-contraceptive-pill-study-finds
- https://www.reuters.com/business/healthcare-pharmaceuticals/belgian-ministry-says-us-funded-contraceptives-still-storage-despite-reports-2025-09-12/
- https://www.fiercepharma.com/marketing/astellas-attacks-menopause-stigma-new-workplace-inclusivity-program
- https://www.firstpost.com/india/pm-mitra-park-on-his-75th-birthday-modi-to-launch-swasth-nari-sashakt-parivar-abhiyaan-in-dhar-13934129.html
- https://www.businesswire.com/news/home/20250916077186/en/Cook-MyoSite-and-Veristat-Partner-in-Complex-Phase-III-Adaptive-Clinical-Study-of-Investigational-Cell-Therapy-for-Unmet-Need-in-Womens-Health
- https://www.fiercepharma.com/marketing/eli-lilly-gives-julianne-moore-new-role-signing-oscar-winning-actor-brain-health-campaign
- https://www.biospace.com/press-releases/us-fda-approves-first-medical-device-for-women-with-asherman-syndrome
- https://www.forbes.com/sites/saibala/2025/09/15/conceivable-life-sciences-raises-50-million-for-ai-automation-and-robotic-precision-in-ivf/